Assessing the performance of a new generic measure of health-related quality of life for children and refining it for use in health state valuation

  • Katherine StevensEmail author
Original Research Article



Previous research to develop a new generic paediatric health-related quality of life (HR-QOL) measure generated 11 dimensions of HR-QOL, covering physical, emotional and social functioning. These dimensions and their response scales were developed from interviews with children. Some of these dimensions have alternative wording choices. The measure is intended to be preference based so that it can be used in paediatric economic evaluation.


The aims of this research were to assess the performance of this new descriptive system in a general and clinical paediatric population, to determine the most appropriate wording for the dimensions and to refine the descriptive system to be amenable to health state valuation to make it suitable for use in economic evaluation.


A sample of 247 children was recruited from general and clinical paediatric populations. Each child completed the descriptive system and data were collected to allow assessment of practicality (including response rates, completion rates and time to complete), content, face and construct validity, whether the child could self-complete and preferences for alternative wordings that could be used for dimensions. These data were used to inform the final choice of wording for dimensions, the scales used for each dimension and the reduction of dimensions to meet the constraints of health state valuation.


The descriptive system demonstrated good practicality and validity in both the general and clinical paediatric samples. The completion rates were excellent (>98%), the mean time to complete was low (3.8 minutes for the general and 5.3 minutes for the clinical sample) and there was evidence of face, content and construct validity. The descriptive system was able to demonstrate significant differences between the general and clinical samples and according to the level of health of children. 96% of the school sample and 85% of the clinical sample were able to self-complete. The final choice of wording for the 11 dimensions was determined by the preferences and comments of the children. To make it amenable for health state valuation, the number of dimensions was reduced from 11 to 9 by removing the dimensions ‘jealous’ and ‘embarrassed’.


The descriptive system performed well in both the general and the clinical populations, and the final descriptive system generates health states that are feasible for health state valuation. Further research is needed to value the final descriptive system by obtaining preference weights for each health state, thereby making the measure suitable for use in paediatric economic evaluation.


Descriptive System Preference Weight School Sample Health State Valuation Psychometric Performance 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



This research was funded as part of a UK Medical Research Council Special Training Fellowship in Health Services and Health of the Public Research. The work was independent of the funders. Thanks go to the staff of Firs Hill Community Primary School and Hunter’s Bar Junior School, the parents who gave their consent and all the children who took part. The Clinical Research Facility at Sheffield Children’s NHS Trust hosted the clinical study and thanks go to the staff on the wards, the parents who gave their consent and the children who took part.

The author has no conflicts of interest that are directly relevant to the content of this study.


  1. 1.
    National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal. London: NICE, 2008 AprGoogle Scholar
  2. 2.
    Australian Government, Department of Health and Ageing. Pharmaceutical Benefits Advisory Committee (PBAC) [online]. Available from URL: [Accessed 2010 Oct 25]
  3. 3.
    Brazier JE, Ratcliffe J, Salomon J, et al. Measuring and valuing health benefits for economic evaluation. 1st ed. Oxford: Oxford University Press, 2007Google Scholar
  4. 4.
    Wille N, Badia X, Bonsel G, et al. Development of the EQ-5DY: a child friendly version of the EQ-5D. Qual Life Res 2010; 19: 875–86PubMedCrossRefGoogle Scholar
  5. 5.
    Moodie M, Richardson J, Rankin B, et al. Predicting time trade-off health state valuations of adolescents in four pacific countries using the AQoL-6D instrument [Monash University Research Paper 2009 (43)]. Melbourne (VIC): Monash University, Centre for Health Economics, 2009Google Scholar
  6. 6.
    Torrance G, Feeny D, Furling W, et al. Multiattribute utility function for a comprehensive health status classification system: health utilities index mark 2. Med Care 1996; 34: 702–22PubMedCrossRefGoogle Scholar
  7. 7.
    Stevens KJ. Working with children to develop dimensions for a preference-based, generic, pediatric health-related quality-of-life measure. Qual Health Res 2010; 20(3): 340–51PubMedCrossRefGoogle Scholar
  8. 8.
    Stevens KJ. Developing a descriptive system for a new preference-based measure of health-related quality of life for children. Qual Life Res 2009; 18(8): 1105–13PubMedCrossRefGoogle Scholar
  9. 9.
    Miller GA. The magical number seven plus or minus two: some limits on our capacity to process information. Psych Rev 1956; 63: 81–97CrossRefGoogle Scholar
  10. 10.
    Brazier JE, Deverill M, Green C, et al. A review of the use of health status measures in economic evaluation. Health Technol Assess 1999; 3(9): i–iv, 1-164PubMedGoogle Scholar
  11. 11.
    Matza LS, Swensen AR, Flood EM, et al. Assessment of health related quality of life in children: a review of conceptual, methodological, and regulatory issues. Value Health 2004; 7(1): 79–92PubMedCrossRefGoogle Scholar
  12. 12.
    Morrow AM, Quine S, Heaton MD, et al. Assessing quality of life in paediatric clinical practice. J Paed Child Health 2010; 46: 323–8CrossRefGoogle Scholar
  13. 13.
    Landgraf JM. Practical considerations in the measurement of HRQoL in child/adolescent clinical trials. In: Fayers P, Hays R, editors. Assessing quality of life in clinical trials. 2nd ed. Oxford: Oxford University Press, 2005: 339–68Google Scholar
  14. 14.
    Dolan P. Modelling valuations for EuroQol Health States. Med Care 1997; 35: 1095–108PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2011

Authors and Affiliations

  1. 1.Health Economics and Decision Science, School of Health and Related ResearchUniversity of SheffieldSheffieldUK

Personalised recommendations